However, none of the published studies have used the VENTANA PD-L1 (SP263) Assay, and in the current study, this assay had a very low failure rate (<1%), potentially because of the stringent requirements for adequate TC content in the tumor tissue samples tested. This evidence concerns the gene CD274 and neoplasm.